Bright Green Corporation (NASDAQ:BGXX) confirmed the launch of their EB-5 website and committed program following their recent U.S. Drug Enforcement Administration approval and registration. The company announced in February that it has commenced utilization of the U.S. Citizenship and Immigration Services’ (USCIS) EB-5 Program to accelerate its 2023 growth strategy and generate significant capital for use in its greenhouse construction and operations in Grants, New Mexico.
The DEA registration followed the completion of a significant process, which culminated with the agency’s site visits and inspections of Bright Green’s agricultural complex in Grants, New Mexico, with the final inspection on March 22, 2023.
Bright Green CEO, Seamus McAuley stated, “Bright Green is delighted to announce the launch of our dedicated EB-5 website to inform and guide potential investors interested in pursuing an EB-5 investment with the company. We are now federally approved and have filed our DEA registration documents with the USCIS, certifying the legal business requirements of the federal program. With access to capital Bright Green is very well-positioned to forge forward and engage our target markets, which have an extremely valuable addressable revenue potential. The company is poised to penetrate diverse market segments ranging from nutritional enhancements, animal health, human medicines and human cosmetics, representing a total addressable market of $18.2 billion.”
Photo by Thiago Patriota on Unsplash
